Please login to the form below

Not currently logged in
Email:
Password:

Acquisition

This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.

Celgene’s Revlimid scores NICE approval in follicular lymphoma

Celgene’s Revlimid scores NICE approval in follicular lymphoma

The approval came only a short time after Bristol-Myers Squibb completed its $74bn acquisition of Celgene.

Latest news

More from news
Approximately 198 fully matching, plus 1,193 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 73 fully matching, plus 84 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 119 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 72 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics